As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: July 5, 2012
by Susan E. Matthews for My Health News Daily:
The diabetes drug metformin may spur the growth of new brain cells, which could have benefits for Alzheimer’s patients, a new Canadian study on mice suggests.
The study showed that metformin caused brain cells to divide, producing new cells.
The diabetes medication was intended to target a specific pathway in liver cells. In the new study, researchers found that the drug activated that same pathway in brain cells, prompting new cell growth, said study researcher Freda Miller, a stem cell biologist and molecular geneticist at the Hospital for Sick Children Research Institute in Toronto.
The new cells that are produced could help to repair the effects of neurodegenerative disorders, such as Alzheimer’s disease, Miller told MyHealthNewsDaily. The concept that new cell growth could repair the brain is also driving research into neural stem cells, she added.
The research on metformin’s effects on the brain is still in early stages, and the findings have yet to be shown in people.
Still, the researchers found that new brain cells grew in both living mice and in human brain cell cultures growing in lab dishes. They are now working to set up clinical trials, Miller said.
The researchers decided to test metformin’s effects on brain cells after it was found that the pathway targeted by the drug in liver cells was also operating in brain cells.
A 2008 study found that patients with both diabetes and Alzheimer’s who began taking metformin experienced improvements in their Alzheimer’s symptoms after starting on the drug. It was thought that treating the patients’ diabetes had effects on the body that helped improve their Alzheimer’s, but the new study suggests the change in brain function was due to the drug itself, the researchers said.
Metformin is currently approved to treat Type 2 diabetes, along with diet and exercise. Studies have suggested the drug has other effects on the body, such as reducing the risk of certain cancers, such as breast cancer or prostate cancer, and regulating metabolism. Experiments with the drug in mice have suggested that it could delay the onset of Huntington’s disease, another brain disorder.
In people with diabetes, the drug has been shown to be very safe, with few side effects.
The study, published today (July 5) in the journal Cell Stem Cell, was funded by the Canadian Institutes of Health Research, the Canadian Stem Cell Network and from the Three To Be Foundation, a charity that supports research on neurological disorders.
Are you an apple or a pear? If you’re not sure, look in the mirror. If the image reflecting back to you shows more roundness around the middle of your body, then...
White women whose genes put them at risk of developing Alzheimer’s disease are more likely than white men with similar risk genes to be diagnosed between the ages of 65 and 75, a study drawing on...
Researchers at the Keck School of Medicine of USC are tackling the sixth-leading cause of death in the United States—Alzheimer’s disease—with a new study that intervenes decades before the disease develops. The school is...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.